| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/29/2001 | US20010047108 Method for making HBED |
| 11/29/2001 | US20010047105 EP4 receptor selective agonists in the treatment of osteoporosis |
| 11/29/2001 | US20010047090 VANILREP1 polynucleotides and VANILREP1 polypeptides |
| 11/29/2001 | US20010047038 Treating the patient suffering for herpes viruses, and cytomegalovirus with an effective amount of sulfur or sulfoxide or sulfonyl containing heteroaromatic compounds |
| 11/29/2001 | US20010047037 Method for non-invasive topical treatment of peyronie's disease, dupuytren's hand contracture and ledederhose fibroisis |
| 11/29/2001 | US20010047036 Administration to a patient suffering from short bowel syndrome an effective amount of a formulation comprising arachidonic acid and docosahexanenoic acid |
| 11/29/2001 | US20010047035 Detecton, treatment and monitoring the patient with poor wound healing ability due to diabetes based on measurement of the breakdown product of nitric oxide (NO) in specimens taken from the patient under controlled conditions |
| 11/29/2001 | US20010047033 Composition for and method of preventing or treating breast cancer |
| 11/29/2001 | US20010047032 Polyhydroxyaromatic or polyhydroxyheteroaromatic compounds are useful for treating Alzheimer's disease, Parkinson's disease and Lewy body disease and others |
| 11/29/2001 | US20010047031 Heterocyclic compounds useful as NMDA receptor selective subtype blockers |
| 11/29/2001 | US20010047029 Diindol-3-ylphenylcarbonium and triindol-3-ylcarbonium derivatives (turbomycins); broad spectrum antibiotic and fungicidal activity |
| 11/29/2001 | US20010047025 Method for treating ocular hypertension |
| 11/29/2001 | US20010047024 Administering 1-(p-aminosulfonyl)phenyl-3-haloalkyl-5-phenylpyrazoles |
| 11/29/2001 | US20010047023 1-(p-(methylsulfonamido)phenyl)-3-trifluoromethyl-5-phenylpyra zolone and derivatives; antiinflammatory agents |
| 11/29/2001 | US20010047022 Especially rofecoxib |
| 11/29/2001 | US20010047021 Tetrasubstituted benzimidazole carbamates |
| 11/29/2001 | US20010047019 3-Aminopyrazole inhibitors of cyclin dependent kinases |
| 11/29/2001 | US20010047018 Novel benzosultam oxazolidinone antibacterial agents |
| 11/29/2001 | US20010047017 Azole derivatives |
| 11/29/2001 | US20010047016 Administering as a melatonin receptor agonist 5-methoxycarbonylamino-N-acetyltryptamine or its analogs; bipolar disease, anxiety |
| 11/29/2001 | US20010047015 1H-1,2,4-Triazole derivative containing an aryl-substituted saturated 1,3-dioxane or 1,3-dioxepane ring |
| 11/29/2001 | US20010047014 4-Benzyl-1-(2-(p-hydroxyphenoxy)ethyl)piperidine-3,4-diol; preparation from 1-(2-haloethoxy)-4-benzyloxybenzene and 4-benzylpiperidine-3,4-diol |
| 11/29/2001 | US20010047012 Glutamate antagonist and an intraocular pressure lowering agent |
| 11/29/2001 | US20010047011 Preventing and treating motor neuron diseases such as ALS |
| 11/29/2001 | US20010047010 Alpha-methyltyrosine and p-fluoro-4-(p-chlorophenyl)-4-(4-hydroxypiperidino)butyropheno ne; optional urine alkalinizer |
| 11/29/2001 | US20010047009 'anti-plaque emulsions and products containing same' |
| 11/29/2001 | US20010047008 Allosteric adenosine receptor modulators |
| 11/29/2001 | US20010047006 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 11/29/2001 | US20010047005 Treating and/or preventing side effects including constipation, vomiting and nausea |
| 11/29/2001 | US20010047004 Oxazolidinone thioamides with piperazine amide substituents |
| 11/29/2001 | US20010047000 E.g., ranolazine |
| 11/29/2001 | US20010046998 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 11/29/2001 | US20010046997 Allosteric inhibitors of pyruvate kinase |
| 11/29/2001 | US20010046996 6-substituted 5H-indolo(2.3b)quinoxalines |
| 11/29/2001 | US20010046995 React with alkylating agents such as mustard gas; may contain perfluoropolymers which are effective barrier compounds for pesticides, industrial solvents and chemical warfare agents |
| 11/29/2001 | US20010046993 5-memberd heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 11/29/2001 | US20010046992 Treatment of urinary tract infections with antibacterial oxazolidinones |
| 11/29/2001 | US20010046991 P-aminoanilino- derivatives |
| 11/29/2001 | US20010046990 (-)3-(4-(2-(phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxypropionic acic or a salt for treating type 2 diabetes |
| 11/29/2001 | US20010046988 Especially treating fibromyalgia, chronic fatigue syndrome, psychogenic pain and chromic pain |
| 11/29/2001 | US20010046987 Potent activity against Grampositive and Gramnegative bacteria |
| 11/29/2001 | US20010046985 Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection |
| 11/29/2001 | US20010046984 Four dosage forms with different release profiles providing for initial release of a beta lactam antibiotic followed by release of a beta-lactamase inhibitor |
| 11/29/2001 | US20010046982 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension |
| 11/29/2001 | US20010046980 Method of treatment of prostate cancer |
| 11/29/2001 | US20010046977 Especially monosodium alendronate trihydrate |
| 11/29/2001 | US20010046976 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 11/29/2001 | US20010046975 Fungicides for the control of take-all disease of plants |
| 11/29/2001 | US20010046974 Catalyzes antithrombin and Factor Xa deactivation by antithrombin |
| 11/29/2001 | US20010046972 Novel immuno-stimulating polysaccharide substance from phellinus spp. strain and use thereof |
| 11/29/2001 | US20010046971 Treatment of osteoarthritis; chrondroprotective agent is preferably a glycosaminoglycan |
| 11/29/2001 | US20010046970 Inhibition of selectin binding |
| 11/29/2001 | US20010046969 Administering a disaccharide such as maltose or trehalose, optionally along with Vitamin C or a derivative, to increase saliva excretion; treating Sjogren's syndrome and xerostomia |
| 11/29/2001 | US20010046968 Angiogenesis inhibition; especially administering naltrexone, naloxone, antibody against OGF or OGF receptor, or antisense molecule of OGF- receptor-encoding gene |
| 11/29/2001 | US20010046967 Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide |
| 11/29/2001 | US20010046964 Drug core with two coated membrane barriers, one of which is composed of an enteric polymer and the other with a combination of an enteric polymer and a water soluble polymer |
| 11/29/2001 | US20010046963 Inhibiting cyclooxygenase-2 biosynthesis and Nuclear factor kappa B synthesis; treatment of arthritis and Alzheimer's disease; administering in food |
| 11/29/2001 | US20010046961 Method for the treatment of solid tumors by albumin microparticles incorporating paclitaxel |
| 11/29/2001 | US20010046959 Method of treating cancer with anti-neurotrophin agents |
| 11/29/2001 | US20010046958 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 11/29/2001 | US20010046957 Administering interferon-alpha or a pegylated derivative and a salt or prodrug of mycophenolic acid |
| 11/29/2001 | US20010046956 May contain another compound to treat diabetes, sexual dysfunction, atherosclerosis, insulin resistance, impaired glucose tolerance, hypercholesterolemia or hypertriglyceridemia |
| 11/29/2001 | US20010046533 With natural isomers of reduced folate such as 5-methyl-6(S)-tetrahydrofolic acid, a food preparation, and/or essential nutrient preparation (other than ascorbic acid) in given molar amounts |
| 11/29/2001 | US20010046522 Herbal supplement for cognitive related impairment due to estrogen loss |
| 11/29/2001 | US20010046521 Administering an effective amount of cytotoxic chemical compound selected from nitrosourea, cyclophophamide, doxorubicin, 5-fluorouracil, cisplatin etc. in first treatment of cancer and squalamine in second treatment step |
| 11/29/2001 | US20010046519 Compositions for nasal administration |
| 11/29/2001 | US20010046509 Use of cinnamic acid or of its derivatives in a cosmetic firming composition |
| 11/29/2001 | US20010046504 Film-coated tablet with cyclophosphamide as active compound, comprising in the core cyclophosphamide, one or more fillers, one or more dry binders but no preswollen starch, flow regulators and lubricants |
| 11/29/2001 | US20010046496 Administering to the human having a disease associated with leukocyte infiltration of mucosal tissues a humanized immunoglobulin or antigen-binding fragment having binidng specificity for alpha 4 beta 7 integrain |
| 11/29/2001 | US20010046491 Thymidine kinase mutant of herpes simplex virus and acyclovir, increased phosphorylation activity |
| 11/29/2001 | US20010046489 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 11/29/2001 | US20010046487 Permeabilizing platelets by acid treatment; temperature and aging resistance |
| 11/29/2001 | US20010046481 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 11/29/2001 | US20010046478 Water soluble lacquers in combination with topical and systemic antimycotics |
| 11/29/2001 | US20010046473 Gastric-retained pharmaceutical composition and method for its use |
| 11/29/2001 | US20010046472 Inclusion of excipients that create a burst release following the initial rapid release, methylphenidate or Ritalin" |
| 11/29/2001 | US20010046471 Infrared thermograpy and methods of use |
| 11/29/2001 | EP1143949A3 19-nor-vitamin d3 compounds with calcemic activity |
| 11/29/2001 | EP1143941A3 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections |
| 11/29/2001 | EP1143916A3 Topical compositions comprising protected functional thiols |
| 11/29/2001 | DE10123349A1 New N-sulfonylated pipecolic acid derivatives, are matrix metalloprotease inhibitors useful e.g. for treating rheumatism, tumor progression, arteriosclerosis or inflammatory bowel disease |
| 11/29/2001 | DE10025949A1 Arzneimittel zur Bekämpfung von Atemdepression Medications to fight respiratory depression |
| 11/29/2001 | DE10025948A1 Wirkstoffkombination Combination of active ingredients |
| 11/29/2001 | DE10025947A1 Wirkstoffkombination enthaltend Montirelin und eine Verbindung mit opioider Wirksamkeit Combination of active ingredients containing Montirelin and connect with opioid activity |
| 11/29/2001 | DE10025946A1 Wirkstoffkombination Combination of active ingredients |
| 11/29/2001 | DE10025890A1 Dosierung von transdermalen Arzneimittelsystemen Dose of transdermal drug delivery systems |
| 11/29/2001 | DE10025728A1 Neue Carbamate und Harnstoffe, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten New carbamates and ureas, their preparation and use as endothelin receptor antagonists |
| 11/29/2001 | DE10025558A1 Topische Zusammensetzung, enthaltend mindestens ein Aryloxim, und Verfahren zu ihrer Herstellung Topical composition comprising at least one aryl oxime, and processes for their preparation |
| 11/29/2001 | DE10025553A1 Zusammensetzung, enthaltend mindestens ein Aryloxim und mindestens einen Wirkstoff zur Behandlung von Akne und ihre Verwendung Composition containing at least one aryl oxime, and at least one active substance for the treatment of acne and their use |
| 11/29/2001 | DE10025308A1 Kombination von Cerivastatin mit ACE Inhibitoren und ihre Verwendung in Arzneimitteln Combination of cerivastatin with ACE inhibitors and their use in medicaments |
| 11/29/2001 | DE10025238A1 Verwendung substituierter 1-Amino-5-phenylpentan-3-ol- und/oder 1-Amino-6-phenylhexan-3-ol- Verbindungen als Arzneimittel Use of substituted 1-amino-5-phenylpentane-3-ol and / or 1-amino-6-phenylhexane-3-ol compounds as medicaments |
| 11/29/2001 | DE10025162A1 Production of alcoholic approximately b-carotene-containing oil-in-water or water-in-oil emulsions for use in the production of liqueurs such as advocaat |
| 11/29/2001 | DE10024939A1 Neue Diphenylmethanderivate für Arzneimittel New diphenylmethane derivatives for pharmaceuticals |
| 11/29/2001 | DE10024752A1 Composition for treating prostate diseases, especially inflammation, hyperplasia or cancer, comprises active agent solution containing dimethyl sulfoxide or hyaluronidase as diffusion promoter, applied using catheter |
| 11/29/2001 | DE10024383A1 Mit toxischen Substanzen beladene dendritische Zellen With toxic substances loaded dendritic cells |
| 11/29/2001 | DE10021894A1 Easily applied pharmaceutical composition for diagnosis and treatment of erectile dysfunction, comprises mixture of active agent, e.g. prostaglandin E1, and carrier forming gel in urethra |
| 11/29/2001 | CA2712547A1 Methods and compositions for treating hepatitis c virus |
| 11/29/2001 | CA2410827A1 Methods and compositions for enhancing the delivery of a nucleic acid toa cell |
| 11/29/2001 | CA2410593A1 Novel mmp-2/mmp-9 inhibitors |
| 11/29/2001 | CA2410531A1 Combination therapy for treatment of depression |